Featured Research

from universities, journals, and other organizations

Avoiding Antibiotic Resistance In Turkeys: Use Bacteriocins Instead To Kill Pathogen

Date:
March 20, 2007
Source:
University of Arkansas, Food Safety Consortium
Summary:
Scientists have found that an effective way to get rid of pathogenic Campylobcter bacteria in turkeys is to use proteins produced naturally by other bacteria. The proteins are called bacteriocins. The researchers found that these proteins can eliminate the detectable Campylobacter and that they can also change conditions in the gut so that the pathogen has fewer places to hide and develop.

A University of Arkansas-led research team has found that an effective way to get rid of pathogenic Campylobcter bacteria in turkeys is to use proteins produced naturally by other bacteria. The proteins are called bacteriocins. The researchers found that these proteins can eliminate the detectable Campylobacter and that they can also change conditions in the gut so that the pathogen has fewer places to hide and develop.

“If we can eliminate Campylobacter, we don’t have to worry about antibiotic resistance,” said Dan Donoghue, a UA Division of Agriculture poultry science researcher who led the project funded by the Food Safety Consortium. The UA group worked with USDA Agricultural Research Service scientists led by Annie Donoghue in Fayetteville, Ark., and Norm Stern in Athens, Ga., along with several Russian government microbiologists.

Campylobacter, which is one of the leading bacterial causes of foodborne illness, has often been the target of antibiotic treatment in poultry. But that approach has its disadvantages. Donoghue explained that the concern is that the Campylobacter in poultry will become resistant to the antibiotics, and that will lead to human consumers becoming sick.

Antibiotics, however, serve useful purposes to prevent disease or to treat sick

birds. So the solution is to eliminate the Campylobacter through other means – in this case, bacteriocins – and then that also eliminates the problems in using antibiotics in poultry for other purposes.

“If there isn’t any Campylobacter in poultry, then it can’t become drug resistant,” Donoghue said. “The use of bacteriocins may allow antibiotics treatment of sick birds without the consequence of antibiotic-resistant Campylobacter.”

Although bacteriocins are effective at eliminating detectable levels of Campylobacter, that leads to the question of what about undetectable levels of the pathogen that might still be in the bird’s system. Donoghue noted that any possible remaining numbers of the pathogen can recolonize inside the bird within a few days. But if the birds are administered doses of bacteriocins just before processing, then the potential problem goes away.

“By the time the bird would get to the consumer, those numbers of Campylobacter – if they do exist – would be at such a low level that they wouldn’t pose a risk to human health,” Donoghue said.

Donoghue’s project is also exploring the effects that bacteriocins have on the bird’s guts. The bacteriocins, after three days of doses, appear to reduce the size of the bird’s crypts (narrow but deep pockets in the intestinal wall), which is where Campylobacter is sequestered.

“It is possible the smaller crypt size, and subsequent greater exposure to the intestinal lumen (cavity area) may change the nutrient or chemical environment limiting Campylobacter growth and colonization,” Donoghue said.

The bacteriocins also appear to reduce the number of goblet cells in a bird’s intestines. The goblet cells excrete mucin, a glycoprotein that serves as an energy source for Campylobacter.

“Since there are fewer goblet cells, that may mean there are less available nutrients to support Campylobacter growth” Donoghue said.


Story Source:

The above story is based on materials provided by University of Arkansas, Food Safety Consortium. Note: Materials may be edited for content and length.


Cite This Page:

University of Arkansas, Food Safety Consortium. "Avoiding Antibiotic Resistance In Turkeys: Use Bacteriocins Instead To Kill Pathogen." ScienceDaily. ScienceDaily, 20 March 2007. <www.sciencedaily.com/releases/2007/03/070319202113.htm>.
University of Arkansas, Food Safety Consortium. (2007, March 20). Avoiding Antibiotic Resistance In Turkeys: Use Bacteriocins Instead To Kill Pathogen. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2007/03/070319202113.htm
University of Arkansas, Food Safety Consortium. "Avoiding Antibiotic Resistance In Turkeys: Use Bacteriocins Instead To Kill Pathogen." ScienceDaily. www.sciencedaily.com/releases/2007/03/070319202113.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins